Neurotech International Limited (ASX:NTI) Insider Robert (Max) Johnston Purchases 500,000 Shares

Neurotech International Limited (ASX:NTI) insider Robert (Max) Johnston bought 500,000 shares of Neurotech International stock in a transaction that occurred on Tuesday, May 7th. The stock was purchased at an average cost of A$0.09 ($0.06) per share, for a total transaction of A$45,000.00 ($29,801.32).

Neurotech International Stock Performance

The company has a debt-to-equity ratio of 1.05, a current ratio of 18.38 and a quick ratio of 3.36.

Neurotech International Company Profile

Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies.